Procurement Summary
Country: USA
Summary: Blood Sample Protein Measurement Analysis
Deadline: 15 May 2026
Posting Date: 02 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140553086
Document Ref. No.: 36C24526Q0481
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The Washington DC VA Medical Center (DC VAMC) is conducting a prospective biospecimen collection and clinical data repository study. Advanced prostate cancer remains a leading cause of cancer morbidity and mortality among Veterans, yet validated circulating biomarkers that predict treatment response or early disease progression are lacking. Current clinical decision-making relies primarily on PSA kinetics and radiographic imaging, which have well-recognized limitations in sensitivity and lead time. The goal of the research study is to generate reproducible, high-quality proteomic data from the study-s longitudinal plasma specimens so that the VA study team can conduct exploratory analyses linking circulating proteomic changes to clinical outcomes, ultimately informing future biomarker validation studies and precision oncology strategies for Veterans with advanced prostate cancer.
Notice ID: 36c24526q0481
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: 245-network contract office 5 (36c245)
Product Service Code: an11 - health r&d services; health care services; basic research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Inactive Dates: may 30, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip